Table VI.

Biological pathways enriched in KEGG of HCC.

KEGG pathway	Genes	P-value	FDR-value
MicroRNAs in cancer	KIF23, E2F1, CCNE2, DNMT3A, PDGFRB, IGF2BP1, DNMT1, STMN1, HMGA2	<0.001	0.037
Pathways in cancer	E2F1, CCNE2, CDKN2B, ITGA6, PDGFRB, LEF1, BIRC5, EGF, AXIN2	<0.001	0.634
Prostate cancer	E2F1, CCNE2, PDGFRB, LEF1, EGF	<0.001	1.031
Cell cycle	E2F1, CCNE2, CDKN2B, CHEK1, MCM6	0.003	3.661
Small cell lung cancer	E2F1, CCNE2, CDKN2B, ITGA6	0.010	10.687
Endometrial cancer	LEF1, EGF, AXIN2	0.028	26.228
Wnt signaling pathway	DKK1, SFRP4, LEF1, AXIN2	0.032	29.532
HTLV–I infection	E2F1, CDKN2B, PDGFRB, CHEK1, TCF3	0.040	35.953
Glioma	E2F1, PDGFRB, EGF	0.042	36.973
Colorectal cancer	LEF1, BIRC5, AXIN2	0.043	37.802
Melanoma	E2F1, PDGFRB, EGF	0.048	41.102

KEGG, Kyoto Encyclopedia of Genes and Genomes; FDR, false discovery rate.